OGN Cash from Financing Activities - Cash Flow Statement - Organon & Co. - IntrinsicAlpha

Organon & Co. OGN

Healthcare - Drug Manufacturers - General - NYSE - US

$ 10.885

-4.41 %

$ 2.81 B

Market Cap

3.19

P/E

OGN - CASH FROM FINANCING ACTIVITIES

Cash from Financing Activities OGN - Organon & Co.

-368 M

LAST VALUE

7.81%

2 YEAR CAGR

32.47%

5 YEAR CAGR

0.00%

10 YEAR CAGR